September 2, 2025

LifeStance Health Group, Inc. (LFST) Stock Analysis: Uncovering a 53% Upside Potential in the Healthcare Sector

LifeStance Health Group, Inc. (NASDAQ: LFST) is a notable player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Scottsdale, Arizona, the..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Unpacking the 19% Potential Upside in the Healthcare Sector

Alphatec Holdings, Inc. (NASDAQ: ATEC) stands out in the healthcare sector, specifically in the medical devices industry, with its innovative solutions for spinal disorder treatments. Headquartered..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: A Biotech Pioneer with a 46.53% Potential Upside

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is carving a niche in the biotechnology sector by leveraging its innovative approach to drug development. Focused on small molecule therapeutics..

NovoCure Limited (NVCR): Investor Outlook on a Promising 120% Upside in Cancer Treatment Innovations

NovoCure Limited (NASDAQ: NVCR) finds itself at the intersection of innovation and investment opportunity within the healthcare sector. As a key player in the medical devices..

Organon & Co. (OGN) Investor Outlook: Evaluating a 39.77% Potential Upside in a Volatile Market

Organon & Co. (NYSE: OGN) stands as a notable entity in the healthcare sector, specifically within the drug manufacturing industry. Headquartered in Jersey City, New Jersey,..

Premier, Inc. (PINC) Stock Analysis: Navigating Challenges with a 3.24% Dividend Yield

Premier, Inc. (NASDAQ: PINC), a prominent player in the healthcare sector, operates as a healthcare improvement company based in Charlotte, North Carolina. With a market capitalization..

Addus HomeCare Corporation (ADUS) Stock Analysis: Healthcare Growth with 22% Potential Upside

Addus HomeCare Corporation (NASDAQ: ADUS), a prominent player in the healthcare sector, is drawing attention from investors due to its strong growth potential and favorable analyst..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Exploring a Promising 18% Upside in Biotech

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) stands out in the biotech industry with a promising blend of innovative therapeutics and robust market potential. Headquartered in Newark, California,..

QuidelOrtho Corporation (QDEL) Stock Analysis: Navigating a 50% Upside Potential Amidst Industry Challenges

QuidelOrtho Corporation (QDEL), a prominent player in the healthcare sector specializing in medical devices, has been capturing investor attention with its intriguing market dynamics and significant..

SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: Navigating the Biotech Landscape with a $3.54 Billion Market Cap

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) stands out in the biotechnology sector with its focus on developing treatments for rare diseases and cancers. The company, headquartered in..

Metsera, Inc. (MTSR) Stock Analysis: Analysts Predict a 67% Upside for This Biotech Innovator

Metsera, Inc. (NASDAQ: MTSR) is capturing the attention of investors with its impressive potential upside, as analysts project a 67.19% increase from its current trading price..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Unpacking the 228% Potential Upside

Viking Therapeutics, Inc. (NASDAQ: VKTX) is capturing the attention of investors with its promising potential upside of 228.20%, according to recent analyst ratings. As a biotech..

Apellis Pharmaceuticals (APLS) Investor Outlook: Analyzing the 39.85% Potential Upside

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) stands out as a compelling opportunity in the biotechnology sector, offering a notable potential upside of 39.85% according to analyst ratings...

Ultragenyx Pharmaceutical Inc. (RARE): Analyst Ratings Signal 187% Potential Upside for Investors

Ultragenyx Pharmaceutical Inc. (RARE), a trailblazer in the biotechnology sector, is focused on addressing rare and ultra-rare genetic diseases through its innovative biopharmaceutical solutions. Headquartered in..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating a 17.88% Potential Upside in the Dental Solutions Market

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is capturing investor attention with a..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: A 32.53% Upside Potential Amidst Robust Buy Ratings

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) stands out in the healthcare sector as a prominent provider of behavioral healthcare services across the United States and Puerto..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 31% Potential Upside in the Diagnostics Sector

Veracyte, Inc. (NASDAQ: VCYT) is a noteworthy player within the healthcare sector, specializing in the diagnostics and research industry. With a market capitalization of $2.39 billion,..

Zai Lab Limited (ZLAB) Stock Analysis: Exploring a 70% Potential Upside in the Biotech Sector

Zai Lab Limited (NASDAQ: ZLAB), a prominent player in the biotechnology sector, is drawing significant attention from investors, thanks to its robust pipeline and exciting market..

Scholar Rock Holding Corporation (SRRK) Investor Outlook: A 53% Potential Upside in Biotech

Scholar Rock Holding Corporation (NASDAQ: SRRK) presents a compelling opportunity for investors interested in the biotechnology sector. With its focus on developing innovative treatments for serious..

Privia Health Group, Inc. (PRVA) Stock Analysis: A Promising 30.86% Upside in the Healthcare Sector

Privia Health Group, Inc. (NASDAQ: PRVA) is making waves within the healthcare sector as a key player in health information services. With a market capitalization of..

Search

Funds

September 2, 2025

Search

Funds

September 2, 2025

FTSE 100

Funds